Vadova Approval Status
FDA Approved: No
Brand name: Vadova
Generic name: carbidopa and levodopa
Dosage form: Extended Release Tablets
Company: IMPAX Laboratories, Inc.
Treatment for: Parkinson's Disease
Vadova is an extended release formulation of carbidopa and levodopa under review for the treatment of Parkinson's disease. The FDA issued a non-approvable letter for Vadova in January 2008.
Development Status and FDA Approval Process for Vadova
|Jan 30, 2008||IMPAX Receives FDA Non-Approvable Letter for Vadova; CompanyConsidering Options|
|Jan 18, 2007||IMPAX Files Amendment to Vadova NDA|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.